Pharma Times
Subscription Required: Yes
Pharma Time delivers the latest updates, analysis, and insights on pharmaceutical industry developments, research, and policy changes.
Latest News
- EpilepsyGTx and ClearPoint Neuro join forces on targeted therapy
- NICE backs finerenone for heart failure
- EC approves Erbitux combination for first‑line treatment of BRAF V600E‑mutant mCRC
- FDA approves Leqembi Iqlik subcutaneous initiation dose for Alzheimer’s disease
- SMC recommends VEOZA for moderate to severe menopausal vasomotor symptoms
- SMC backs Columvi combination for second-line lymphoma treatment in Scotland
- Pluripotent stem cell trial for Huntington’s disease